Evidence map›Paper›PMID 27229718›Full record

GuidelineHepatology international2016

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.

Masao Omata, Tatsuo Kanda, Lai Wei, Ming-Lung Yu, Wang-Long Chuang, Alaaeldin Ibrahim, Cosmas Rinaldi Adithya Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal and 11 more

Abstract readConsensus StatementPractice GuidelineReview
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Hepatology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Masao OmataYamanashi Prefectural Central Hospital, 1-1-1 Fujimi, Kofu-shi, Yamanashi, 400-8506, Japan. momata-tky@umin.ac.jp.
Tatsuo KandaGraduate School of Medicine, Chiba University, Chiba, Japan.
Lai WeiPeking University People's Hospital, Peking University Hepatology Institute, Beijing, China.
Ming-Lung YuKaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Wang-Long ChuangHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Alaaeldin IbrahimGI/Liver Division, Department of Internal Medicine, University of Benha, Banha, Egypt.
Cosmas Rinaldi Adithya LesmanaDigestive Disease and GI Oncology Center, Medistra Hospital, University of Indonesia, Jakarta, Indonesia.
Jose SollanoUniversity Santo Tomas Hospital, Manila, Philippines.
Manoj KumarDepartment of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Ankur JindalDepartment of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Barjesh Chander SharmaDepartment of Gastroenterology, G.B. Pant Hospital, New Delhi, India.
Saeed S HamidDepartment of Medicine, Aga Khan University and Hospital, Stadium Road, Karachi, 74800, Pakistan.
A Kadir DokmeciDepartment of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
Mamun Al-MahtabDepartment of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, 1000, Bangladesh.
Geofferey W McCaughanRoyal Prince Alfred Hospital, Centenary Institute, University of Sydney, Sydney, Australia.
Jafri WasimDepartment of Medicine, Aga Khan University and Hospital, Stadium Road, Karachi, 74800, Pakistan.
Darrell H G CrawfordUniversity of Queensland, School of Medicine, Woolloongabba, QLD, 4102, Australia.
Jia-Horng KaoNational Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan.
Osamu YokosukaGraduate School of Medicine, Chiba University, Chiba, Japan.
George K K LauThe Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China.
Shiv Kumar SarinDepartment of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on "APASL consensus statements and recommendations for management of hepatitis C" in March 2015 to revise the "APASL consensus statements and management algorithms for hepatitis C virus infection" (Hepatol Int 6:409-435, 2012). The working party consisted of expert hepatologists from the Asian-Pacific region gathered at the Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed, and debated during the course of drafting a revision. Participants of the consensus meeting assessed the quality of the cited studies. The finalized recommendations for hepatitis C prevention, epidemiology, and laboratory testing are presented in this review.

Indexed as

Antiviral AgentsDisease ManagementHepacivirusHepatitis CHumansAntiviral Agents

Identifiers

PMID27229718
PMCPMC5003900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.